Mirena Lawsuits Move Ahead, as Case Management Conference is Convened in New Jersey Litigation, Bernstein Liebhard LLP Reports


New York, New York (PRWEB) July 04, 2013

Mirena lawsuit claims filed on behalf of ladies who have allegedly suffered significant complications, such as spontaneous device migration and uterine perforations, due to their use of the IUD, are moving forward in each state and federal courts, Bernstein Liebhard LLP reports. Court documents indicate that a Case Management Conference was held on July 1st in the consolidated litigation established for Mirena IUD lawsuits in New Jerseys Bergen County Superior Court. According to an Order issued by the Court on July 2nd, attorneys for the parties have been directed to meet and confer within 30 days to reach agreement on a quantity of issues, including the status, scope, parameters and timing of discovery. The Court also scheduled the litigations next Case Management Conference for August 13, 2013. (In Re: Mirena Litigation Case No. 297)

&#13

Our Firm is actively representing women in Mirena lawsuits, and we continue to hear from alleged victims of critical Mirena complications, including spontaneous device migration and uterine perforations. We are pleased to see this litigation moving forward, says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm continues to provide free of charge legal evaluations to alleged victims of Mirena side effects.

&#13

Mirena IUD Lawsuits&#13

The Mirena IUD was approved by the U.S. Food &amp Drug Administration (FDA) as a birth control strategy in 2000, and later as a remedy for heavy menstrual bleeding in females who wish to use an IUD as their main form of birth handle. According to court documents, Mirena lawsuits allege that Bayer Healthcare Pharmaceuticals downplayed its severe risks and failed to supply sufficient warnings concerning the prospective for spontaneous migration of the Mirena IUD. In addition to the consolidated litigation now underway in New Jersey Superior Court, a multidistrict litigation was not too long ago established in U.S. District Court, Southern District of New York for all federally-filed Mirena IUD lawsuits. A Status Conference in the federal multidistrict litigation was held on July 2nd. (In re: Mirena IUD Items Liability Litigation, MDL No. 2434)

&#13

According to a June 17th report from NewsChannel5 in Cleveland, the FDA has received more than 70,000 adverse occasion reports involving Mirena given that the device was launched in 2000. Information from the FDA also indicated that given that 2008, the agency had received a lot more than 4,700 complaints of device dislocation involving Mirena, and 1,300 reports of uterine perforations. Despite these mounting adverse event reports, there has been no indication that Bayer may be arranging to announce a Mirena IUD recall any time in the future.*

&#13

Whilst a Mirena recall does not appear imminent, the FDA has taken problem in the past with some of the claims Bayer has utilised in marketing campaigns for the IUD. In 2009, the agency issued a warning letter to Bayer after obtaining that its Mirena promotions overstated the efficacy of the device and minimized its dangers. Amongst other items, the letter cited Bayer for producing statements that indicated that Mirena would assist a lady look and really feel wonderful, and enhance her sex life.**

&#13

Ladies who have allegedly suffered significant Mirena complications following spontaneous migration of the IUD may be entitled to compensation for their health-related bills, lost wages, discomfort and suffering and other damages. To find out a lot more about Mirena lawsuits, please go to Bernstein Liebhard LLPs site. To arrange for a cost-free evaluation of your potential Mirena IUD lawsuit, please contact 800-511-5092.

&#13

*newsnet5.com/dpp/news/local_news/investigations/thousands-of-females-complain-about-harmful-complications-from-mirena-iud-birth-handle&#13

*http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/WarningLettersandNoticeofViolationLetterstoPharmaceuticalCompanies/UCM197229.pdf

&#13

About Bernstein Liebhard LLP &#13

Bernstein Liebhard LLP is a New York-primarily based law firm exclusively representing injured persons in complex person and class action lawsuits nationwide because 1993, such as these who have been harmed by harmful drugs, defective medical devices and customer products. The firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the nation, for the previous 10 consecutive years.

&#13

Bernstein Liebhard LLP &#13

10 East 40th Street &#13

New York, New York 10016 &#13

800-511-5092

&#13

Attorney Marketing.